Martin Currie LTD Pfizer Inc Transaction History

Martin Currie LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$30.12 - $36.54 $576,798 - $699,741	-19,150 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$38.47 - $43.86 $3.03 Million - $3.46 Million	-78,806 Reduced 80.45%	19,150 $836,000
Q3 2018 Nov 14, 2018	SELL	$34.47 - $41.81 $5.89 Million - $7.14 Million	-170,836 Reduced 63.56%	97,956 $4.32 Million
Q4 2017 Feb 14, 2018	SELL	$33.26 - $35.29 $1.88 Million - $2 Million	-56,584 Reduced 17.39%	268,792 $9.74 Million
Q3 2017 Nov 14, 2017	SELL	$31.0 - $34.15 $279,620 - $308,033	-9,020 Reduced 2.7%	325,376 $11.6 Million
Q2 2017 Aug 14, 2017	BUY	N/A	334,396	334,396 $11.2 Million

3,256

3.62B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $144B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Martin Currie LTD, based on Form 13F filings with the SEC.

Stay updated on Martin Currie LTD with notifications on news.